|
Volumn 251, Issue 4, 2002, Pages 307-316
|
A rapid increase in β-cell function by multiple insulin injections in type 2 diabetic patients is not further enhanced by prolonging treatment
|
Author keywords
C peptide glucagon test; Hyperglycaemia; Insulin secretion; Insulin sensitivity; Insulin treatment; Type 2 diabetes
|
Indexed keywords
C PEPTIDE;
GLIBENCLAMIDE;
GLUCAGON;
GLUCOSE;
INSULIN;
ISOPHANE INSULIN;
NEUTRAL INSULIN;
ADULT;
AGED;
ARTICLE;
CELL FUNCTION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIET RESTRICTION;
DISEASE COURSE;
DOSE RESPONSE;
DRUG EFFECT;
DRUG WITHDRAWAL;
FEMALE;
FOLLOW UP;
GLUCOSE BLOOD LEVEL;
HUMAN;
INSULIN INFUSION;
INSULIN RELEASE;
INSULIN SENSITIVITY;
LONG TERM CARE;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PANCREAS ISLET BETA CELL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
WEIGHT GAIN;
BLOOD GLUCOSE;
DIABETES MELLITUS, TYPE 2;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GLUCAGON;
GLYBURIDE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
ISLETS OF LANGERHANS;
MALE;
MIDDLE AGED;
|
EID: 0036274789
PISSN: 09546820
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2796.2002.00956.x Document Type: Article |
Times cited : (19)
|
References (17)
|